Research of ribomomal protein L23 in tumor progression / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 835-837, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-501903
ABSTRACT
Ribosomal protein L23 is a new target for gene therapy of cancer.It participates in tumor progression by activating p53,inactivating murine double minute 2,regulating the carcinogenic activity of c-Myc,inducing the multi-drug resistance,and affecting the biologic behaviour of tumors.Generally,it′s con-sidered to be a potential prognostic factor in human cancers.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS